Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.

Sugano K, Kontani T, Katsuo S, Takei Y, Sakaki N, Ashida K, Mizokami Y, Asaka M, Matsui S, Kanto T, Soen S, Takeuchi T, Hiraishi H, Hiramatsu N.

J Gastroenterol. 2012 May;47(5):540-52. doi: 10.1007/s00535-012-0541-z. Epub 2012 Mar 3.

2.

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.

Sugano K, Matsumoto Y, Itabashi T, Abe S, Sakaki N, Ashida K, Mizokami Y, Chiba T, Matsui S, Kanto T, Shimada K, Uchiyama S, Uemura N, Hiramatsu N.

J Gastroenterol. 2011 Jun;46(6):724-35. doi: 10.1007/s00535-011-0397-7. Epub 2011 Apr 16.

3.
4.

Endoscopic evaluation of low-dose aspirin-induced gastric and duodenal ulcers during prophylaxis with lansoprazole.

Sakaki N, Ashida K, Mizokami Y, Chiba T, Matsui S, Kanto T, Uemura N, Hiramatsu N, Sugano K.

Hepatogastroenterology. 2013 Jun;60(124):762-7. doi: 10.5754/hge12920. Epub 2013 Mar 11.

PMID:
23478070
5.

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.

Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B; NSAID-Associated Gastric Ulcer Prevention Study Group..

Arch Intern Med. 2002 Jan 28;162(2):169-75.

PMID:
11802750
6.
7.

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.

Raskin JB, White RH, Jackson JE, Weaver AL, Tindall EA, Lies RB, Stanton DS.

Ann Intern Med. 1995 Sep 1;123(5):344-50.

PMID:
7625622
9.

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.

Taha AS, Hudson N, Hawkey CJ, Swannell AJ, Trye PN, Cottrell J, Mann SG, Simon TJ, Sturrock RD, Russell RI.

N Engl J Med. 1996 May 30;334(22):1435-9.

10.

Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.

Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.

Am J Gastroenterol. 1996 Feb;91(2):223-7.

PMID:
8607484
11.

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group.

Graham DY, White RH, Moreland LW, Schubert TT, Katz R, Jaszewski R, Tindall E, Triadafilopoulos G, Stromatt SC, Teoh LS.

Ann Intern Med. 1993 Aug 15;119(4):257-62.

PMID:
8328732
12.

Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.

Sanuki T, Fujita T, Kutsumi H, Hayakumo T, Yoshida S, Inokuchi H, Murakami M, Matsubara Y, Kuwayama H, Kawai T, Miyaji H, Fujisawa T, Terao S, Yamazaki Y, Azuma T; Care Study Group..

J Gastroenterol. 2012 Nov;47(11):1186-97. doi: 10.1007/s00535-012-0588-x. Epub 2012 Apr 17.

PMID:
22526273
13.

Prevention of NSAID-induced gastroduodenal ulcers.

Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, McGowan J.

Cochrane Database Syst Rev. 2002;(4):CD002296. Review.

PMID:
12519573
14.

Prevention of NSAID-induced gastroduodenal ulcers.

Rostom A, Wells G, Tugwell P, Welch V, Dube C, McGowan J.

Cochrane Database Syst Rev. 2000;(4):CD002296. Review. Update in: Cochrane Database Syst Rev. 2002;(4):CD002296.

PMID:
11034748
16.

Prevention of chronic NSAID induced upper gastrointestinal toxicity.

Rostom A, Wells G, Tugwell P, Welch V, Dube C, McGowan J.

Cochrane Database Syst Rev. 2000;(3):CD002296. Review. Update in: Cochrane Database Syst Rev. 2000;(4):CD002296.

PMID:
10908548
17.

Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.

Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.

Am J Med. 2005 Nov;118(11):1271-8.

PMID:
16271912
20.

Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.

Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C.

Am J Gastroenterol. 2006 Apr;101(4):701-10. Epub 2006 Feb 22.

PMID:
16494585

Supplemental Content

Support Center